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Abstract
Background: Merkel cell carcinomas are rare neoplasm of neuroendocrine origin, usually
observed in elderly people in areas with abundant sunlight, and predominantly located on the head
and neck, extremities, and trunk. In many patients, a local recurrence after resection of the primary
tumour and even distant metastases can be found.
Case presentation: We report an unusual occurrence of pancreatic metastases from a
previously diagnosed Merkel cell carcinoma with the discovery of a concomitant insulinoma. An 82-
year old lady suffered from recurrent attacks of hypoglycemia and presented with an abdominal
mass, 2 years prior she had an excision done on her eyebrow that was reported as Merkel cell
carcinoma. An extended distal pancreatectomy and splenectomy along with resection of the left
flexure of the colon for her abdominal mass was carried out. Final histopathology of the mass was
a poorly differentiated endocrine carcinoma in the pancreatic tail, in the peripancreatic tissue and
in the surrounding soft tissue consistent with metastatic Merkel cell carcinoma in addition to an
insulinoma of the pancreatic body.
Conclusion: This is the first documented case of a metastatic Merkel cell carcinoma and a
concomitant insulinoma, suggesting either a mere coincidence or an unknown neuroendocrine
tumor syndrome.
Background
Merkel cell carcinoma is a rare cutaneous neoplasm of
neuroendocrine origin, usually observed in elderly people
in areas with abundant sunlight. Affected skin areas are
predominantly the head and neck, but the extremities and
trunk are other predisposed areas [1-4]. In a review of
1024 patients, the primary tumour was found on the head
and neck in 40% of the patients, in 33% on the
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reported cases this cancer could be found in Caucasians,
suggesting possible protection by darker skin pigmenta-
tion [5]. While the exact incidence remains unknown,
Hodgson found an increase in the incidence of Merkel cell
carcinoma from 0.15 cases per 100,000 in 1986 to around
0.44 cases per 100,000 in 2001; the highest incidence of
4.28 per 100,000 was found in patients over 85 years [6].
The literature review of 1024 patients showed a mean age
of 69 years at diagnosis [5]. We report an unusual occur-
rence of pancreatic metastases from a previously diag-
nosed Merkel cell carcinoma with the discovery of a
concomitant insulinoma.
Case presentation
A 82-year old lady presented to the Department of Gen-
eral Surgery at the University of Heidelberg, Germany
with recurrent attacks of hypoglycemia and a large
abdominal mass. While diagnostic tests repeatedly docu-
mented glucose levels below 40 mg/dl (normal levels 80
– 120 mg/dl), a computed tomography (CT) (Figure 1A,
B) scan of the abdomen revealed a large lesion of around
5 to 6 cm in relation to the pancreatic body and tail. There
were also large masses of about 3–5 cm in the retroperito-
neum and in the area of the celiac trunk and around the
mesenteric artery. Furthermore, in the pancreatic body
there was a hypervascularized area (Figure 2), that was
suspicious for an insulinoma. Clinically this lady, who
was not thriving, reported a weight loss of 12 kilograms
over the previous 4 months. A somatostatin receptor scin-
tigraphy showed an enhanced uptake in the region of the
pancreatic body/tail as well as in the right axilla (a palpa-
ble mass was also noted there) and excluded the possibil-
ity of other involved areas.
She gave a past history of an operation done on the right
eyebrow 2 years prior for a 0.8 × 0.8 cm lesion (Figure 3)
that was reported as a Merkel cell carcinoma. Histopathol-
ogy showed rather uniform tumor cells in a trabecular
growth pattern (Figure 4a) with monomorphous pale-
stained nuclei and many mitoses (Figure 4b). There was
invasion of dermal lymphatics and blood vessels (Figure
Computed tomography scan of the abdomen revealed a large lesion of 5 t  6 cm in relation to the pancr atic body and tail(venous phase A, B, arrows)Figure 1
Computed tomography scan of the abdomen revealed a large 
lesion of 5 to 6 cm in relation to the pancreatic body and tail 
(venous phase A, B, arrows).
Arterial phase of the computed tomography scan of the abdomen shows a ypervascularized area (arrows) in the panc eatic b dyFigu e 2
Arterial phase of the computed tomography scan of the 
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itivity for cytokeratin 20 (Figure 4c) and neurofilament
(not shown) in the characteristic dot-like pattern and a
weak expression of chromogranin A (Figure 4d). After
excision, radiation therapy was also administered only at
the site of the primary lesion, the draining lymphatic ves-
sels and the first lymph node station. A year later, a large
abdominal mass was noted of uncertain origin and an
ultrasound guided biopsy showed an unspecified small
cell cancer. In view of the large mass with additional sus-
picious areas being noted in the spleen, left adrenal gland
and axilla, she had been subjected to palliative radiother-
apy of 30 Gray over 2 months. However no definitive
diagnosis of metastasis in these areas was established.
With a working clinical diagnosis of symptomatic insuli-
noma not responding to medical measures, a decision for
surgical resection of this large lesion was inevitable, the
age of the patient and the previous history of palliative
radiation just 6 months prior notwithstanding.
Operative details
Surgical exploration revealed a large mass of about 5 cm
in the tail of the pancreas, in close proximity to the spleen
and the splenic flexure of the transverse colon. However
there was no evidence of any metastatic disease to the
liver, peritoneum and the adnexae. After a careful and
meticulous mobilization, a distal pancreatectomy,
splenectomy, and adrenalectomy along with resection of
the splenic flexure of the colon were performed.
Pathological examination revealed a tumor with manifes-
tations in the pancreatic tail, the adrenal gland, the peri-
pancreatic tissue, and the surrounding soft tissue. Grossly,
the mass displayed a whitish and glassy cut surface, con-
taining extended areas of haemorrhage and necrosis. His-
tologically, the tumor displayed endocrine architecture
with mostly solid formations of rather monomorphic
cells. The tumor was mitotically highly active (mitotic
count >10 per high power field) and contained abundant
areas of necrosis. Immunohistochemically, the tumor
cells were strongly positive for the endocrine marker syn-
aptophysin and for cytokeratin 20 while there was no
expression of insulin. The proliferative activity (MIB-1)
reached approximately 80% (Figure 5).
Furthermore, gross examination of the resected specimen
revealed a well demarcated, brownish tumor of the pan-
creatic body, measuring 1.2 cm in diameter. This tumor
microscopically displayed endocrine architecture with
trabecular arrangements of uniform tumor cells, showing
no mitotic activity. Immunohistochemistry revealed
strong positivity for synaptophysin as well as focal positiv-
ity for insulin. The proliferative activity (MIB-1) was
approximately 1% (Figure 6). The diagnosis of a poorly
differentiated endocrine carcinoma (Merkel cell carci-
noma) along with that of benign pancreatic insulinoma
was thus made.
The patient had a smooth postoperative recovery, the
bouts of hypoglycaemia completely disappeared, and she
was discharged home within 3 weeks of surgery. She is
presently asymptomatic and remains on regular follow
up.
Discussion
Though a very rare tumor, Merkel cell carcinoma is inher-
ently aggressive. The cells of origin are thought to be Mer-
kel cells, which are neuroendocrine cells present in the
basal layer of the epidermis. However the exact origin is
controversial since often on immunohistological exami-
nation both epidermal and neuroendocrine features can
be found. This tumor has a high tendency for local recur-
rence [2,7-9]. While in up to 50% of patients local recur-
rence after excision is observed, most are diagnosed
within two years of the primary resection [1]. 50 – 75% of
the patients develop lymph node metastases [5,9-12]. Dis-
tant metastases are described in many cases [1,5,7,8,13].
The survival depends on the treatment and the stage at
diagnosis. In a study of 251 patients, the 5-year survival
rate was 97% for those who had no positive lymph nodes
on histological examination. In contrast the 5-year sur-
vival was 52% in those who presented with positive
lymph nodes [1]. Shalhub et al, reported on a case of met-
astatic Merkel cell cancer. In their case the patient showed
a lymph node in the axilla and in the groin. At the same
time a CT scan showed multiple enlarged portocaval and
gastrohepatic lymph nodes as well as a small lesions in the
vicinity of the colon, which were metastatic Merkel cell
carcinoma on histological examination [13].
Merkel cell carcinoma on the right eyebrowFigure 3
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improved outcomes. Surgery and adjuvant radiotherapy
provide good local control of the primary tumor [5]. A ret-
rospective study of 35 patients suffering from Merkel cell
carcinoma showed that wide excision, lymph node dissec-
tion and adjuvant radiotherapy decreased the loco-
regional recurrence, and patients had a better survival
[14]. In a review of 1024 patients, the recurrence rate was
10.5% in those who received radiotherapy in comparison
to 52.6% without radiation following resection [5].
Pancreatic Metastases from Merkel Cell Cancer
The majority of the neoplasms in the pancreas have their
origin in the organ itself. In a study examining 973 surgi-
cal specimen, only 38 metastatic tumors to the pancreas
were noted [15]. The origin of pancreatic metastases were
lymphomas, carcinomas of stomach, kidney, lung and
others, as well as a Merkel cell carcinoma [15]. A Medline
search with the key words Merkel cell cancer, Merkel cell car-
cinoma, metastatic disease, pancreatic metastases and surgical
treatment revealed two additional reports of pancreatic
metastasis from a Merkel cell carcinoma: One patient had
a 4 cm violaceous firm subcutaneous nodule of the left
Merkel cell carcinoma – primary tumorFigure 4
Merkel cell carcinoma – primary tumor. A, B: Hematoxylin and eosin staining. A. Lower magnification showing intravasal tumor 
cells. B: Monomorphous tumor cells, pale staining nuclei, many mitotic figures. C: Strong cytokeratin 20 staining. Insert: Intra-
vasal cytokeratin 20-positive tumor cells. D: Weak chromogranin A stainingPage 4 of 7
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nation were unremarkable. A biopsy confirmed that as
Merkel cell tumor. Later this patient presented with jaun-
dice and a cystic lesion (approximately 5 cm in diameter)
in the pancreas. Subsequent laparoscopy showed evi-
dence of peritoneal carcinomatosis, which was histologi-
cal confirmed as a metastasis of the primary Merkel
carcinoma [7]. In another case report, a 64-year old man
presented with a short history of jaundice. A CT scan of
the abdomen showed a large 6 cm mass in the head of the
pancreas. Histological examination revealed a metastasis
of Merkel cell carcinoma approximately two years after
resection of a Merkel cell carcinoma resected from his
finger [8]. As regards the role of imaging in Merkel cell car-
cinoma, clinical information is still insufficient to fully
appreciate the role of imaging in the management of this
condition. A better imaging algorithm is expected with
increased awareness and improved clinical understanding
of this uncommon neoplasm. Currently, CT scan, along
with magnetic resonance imaging, appears to be imaging
modality of choice. Contrast enhanced computed tomog-
raphy (CT) demonstrates high-attenuation adenopathy
and soft-tissue nodules. Solid abdominal organs targeted
by metastasis manifest as hypervascular lesions with ring-
like enhancement [16,17].
Our case adds some more information to the existing pool
of knowledge about this tumor. It is well documented that
Merkel cell carcinoma metastasis in the pancreasFigure 5
Merkel cell carcinoma metastasis in the pancreas. A, B: Hematoxylin and Eosin staining. C: Synaptophysin staining. D: Cytoker-
atin 20 staining.
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adequate surgical resection and the addition of radiother-
apy [2,18]. In systemic disease, many combinations of
chemotherapeutic agents have been used with poor
results [19]; although in a recent study, Merkel cell carci-
noma was chemosensitive but rarely chemocurable in
patients with metastases or locally advanced tumors [20].
While this elderly lady was possibly subjected to palliative
radiotherapy given the extent of her abdominal mass, her
unrelenting symptoms and the fact that age over 60 years
is a poor prognostic factor in Merkel cell carcinoma
prompted us to consider a surgical resection in spite of her
advanced age. However, the symptoms (severe hypoglyc-
emia) were not related to the metastatic Merkel cell carci-
noma, but to the concomitant insulinoma. While her
symptoms completely resolved due to excision of the
insulinoma, the R0 excision of the Merkel cell carcinoma
could also be expected to provide survival benefit; how-
ever this remains to be seen on longer follow-up.
Interestingly, Fincher et al reported a Merkel cell carci-
noma with a concomitant somatostatinoma. Our case is
the second case of Merkel cell carcinoma with a
concomitant endocrine tumor. As already speculated by
Fincher et al, this "occurrence may represent a previously
undescribed neuroendocrine tumor syndrome, and this
possibility should be considered when either tumor is
diagnosed" [21]. Modern molecular biological methods
Insulinoma in the pancreatic bodyFigure 6
Insulinoma in the pancreatic body. A, B: Hematoxylin and Eosin staining. C: Insulin staining (note the focal positivity). D: Synap-
tophysin staining.
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may help to elucidate whether common molecular altera-
tions are present in these tumor types.
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